KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) Enterprise Value (2016 - 2026)

Chemed filings provide 18 years of Enterprise Value readings, the most recent being -$16.9 million for Q1 2026.

  • For the quarter ending Q1 2026, Enterprise Value rose 90.31% year-over-year to -$16.9 million, compared with a TTM value of -$16.9 million through Mar 2026, up 90.31%, and an annual FY2025 reading of -$74.5 million, up 58.22% over the prior year.
  • Enterprise Value hit -$16.9 million in Q1 2026 for Chemed, up from -$74.5 million in the prior quarter.
  • The five-year high for Enterprise Value was -$7.8 million in Q3 2022, with the low at -$313.3 million in Q1 2024.
  • Median Enterprise Value over the past 5 years was -$159.9 million (2023), compared with a mean of -$139.0 million.
  • The sharpest move saw Enterprise Value soared 91.36% in 2022, then crashed 2125.29% in 2023.
  • Year by year, Enterprise Value stood at -$74.1 million in 2022, then plummeted by 256.09% to -$264.0 million in 2023, then surged by 32.43% to -$178.4 million in 2024, then soared by 58.22% to -$74.5 million in 2025, then surged by 77.38% to -$16.9 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$16.9 million, -$74.5 million, and -$129.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.